Article info
Poster sessions
Treating asthma
P2 Evaluation of Switching Therapy from Fixed-Dose Combination Inhaled Corticosteroid/Long-Acting Beta2agonist to Beclometasone Dipropionate/Formoterol (Fostair 100/6®)
Citation
P2 Evaluation of Switching Therapy from Fixed-Dose Combination Inhaled Corticosteroid/Long-Acting Beta2agonist to Beclometasone Dipropionate/Formoterol (Fostair 100/6®)
Publication history
- First published November 19, 2012.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.